Data / Form D filings / Groove Biopharma Corp
Groove Biopharma Corp: Form D filings
Groove Biopharma Corp, a health care company in Seattle, WA, filed 2 Form D notices with the SEC between 2010 and 2011. The latest, on December 20, 2011, reports $4.5 million sold of a $6 million offering to 7 investors.
Find out what Groove Biopharma Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1616 Eastlake Avenue E., Suite 202, Seattle, WA, 98102
- Phone
- (206) 957-7300
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2008
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1443563
The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 20, 2011 | New notice | $6,000,000 | $4,499,999 | $1,500,001 | 7 | Dec 7, 2011 | sec.gov |
| Apr 28, 2010 | New notice | Indefinite | $3,900,000 | Indefinite | 7 | Apr 16, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Steven Gillis | Director | |
| David Schubert | Executive Officer | |
| Thong Le | Director | |
| Lindsay Rayle | Executive Officer | |
| Brian Atwood | Director | |
| Merl F. Hoekstra | Director | |
| Carl Weissman | Executive Officer, Director | |
| Chad Waite | Director |
Other health care companies in Washington that filed recently
- Seattle Neurosound Solutions, Inc. $100,000 · Sep 22, 2026
- DexCare, Inc. $12.9 million · Sep 14, 2026
Every Form D from the week of Dec 19, 2011 · All recent filings in Washington · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Groove Biopharma Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.